Funder
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
AstraZeneca
Massachusetts Institute of Technology
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference15 articles.
1. International patterns and trends in endometrial cancer incidence, 1978–2013;Lortet-Tieulent;JNCI J Natl Cancer Inst,2018
2. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study;Morrow;Gynecol Oncol,1991
3. Paraaortic lymph node evaluation in stage I endometrial carcinoma;Piver;Obstet Gynecol,1982
4. Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus;Hicks;Int J Radiat Oncol Biol Phys,1993
5. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): Final results of an international, open-label, multicentre, randomised, phase 3 trial;de Boer;Lancet Oncol,2018